[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

HK1113162A1 - Treatment of fungal and/or protist infections - Google Patents

Treatment of fungal and/or protist infections

Info

Publication number
HK1113162A1
HK1113162A1 HK08108780.9A HK08108780A HK1113162A1 HK 1113162 A1 HK1113162 A1 HK 1113162A1 HK 08108780 A HK08108780 A HK 08108780A HK 1113162 A1 HK1113162 A1 HK 1113162A1
Authority
HK
Hong Kong
Prior art keywords
fungal
treatment
peptides
treating
preventing
Prior art date
Application number
HK08108780.9A
Other languages
English (en)
Inventor
Curtis Dobson
Original Assignee
Ai2 Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ai2 Ltd filed Critical Ai2 Ltd
Publication of HK1113162A1 publication Critical patent/HK1113162A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
    • A01N37/18—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing the group —CO—N<, e.g. carboxylic acid amides or imides; Thio analogues thereof
    • A01N37/30—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing the group —CO—N<, e.g. carboxylic acid amides or imides; Thio analogues thereof containing the groups —CO—N< and, both being directly attached by their carbon atoms to the same carbon skeleton, e.g. H2N—NH—CO—C6H4—COOCH3; Thio-analogues thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/775—Apolipopeptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Wood Science & Technology (AREA)
  • Environmental Sciences (AREA)
  • Dentistry (AREA)
  • Plant Pathology (AREA)
  • Pest Control & Pesticides (AREA)
  • Agronomy & Crop Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Materials For Medical Uses (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
HK08108780.9A 2005-06-28 2008-08-08 Treatment of fungal and/or protist infections HK1113162A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0513096.8A GB0513096D0 (en) 2005-06-28 2005-06-28 Treatment of microbial infections
PCT/GB2006/002350 WO2007000584A1 (en) 2005-06-28 2006-06-26 Treatment of fungal and/or protist infections

Publications (1)

Publication Number Publication Date
HK1113162A1 true HK1113162A1 (en) 2008-10-24

Family

ID=34856225

Family Applications (1)

Application Number Title Priority Date Filing Date
HK08108780.9A HK1113162A1 (en) 2005-06-28 2008-08-08 Treatment of fungal and/or protist infections

Country Status (15)

Country Link
US (3) US20080207508A1 (ko)
EP (1) EP1896502B1 (ko)
JP (1) JP2008546831A (ko)
KR (2) KR20080030060A (ko)
CN (1) CN101208355A (ko)
AU (1) AU2006263600B2 (ko)
BR (1) BRPI0612103A2 (ko)
CA (1) CA2610720A1 (ko)
DK (1) DK1896502T3 (ko)
ES (1) ES2427171T3 (ko)
GB (1) GB0513096D0 (ko)
HK (1) HK1113162A1 (ko)
PL (1) PL1896502T3 (ko)
RU (1) RU2008102928A (ko)
WO (1) WO2007000584A1 (ko)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0329958D0 (en) 2003-12-24 2004-01-28 Univ Manchester Treatment of viral infections
GB0404374D0 (en) 2004-02-27 2004-03-31 Univ Manchester Treatment of bacterial infections
GB0513096D0 (en) 2005-06-28 2005-08-03 Strathclyde Treatment of microbial infections
ITTO20080894A1 (it) * 2008-12-02 2010-06-03 Bioindustry Park Del Canavese S P A Uso dell'aptoglobina, peptidi leganti l'aptoglobina, polimeri contenenti gli stessi e loro uso
JP5463515B2 (ja) * 2009-02-12 2014-04-09 独立行政法人農業生物資源研究所 抗微生物ペプチドを固定化した素材
EP2892913A4 (en) * 2012-09-07 2017-01-18 Agency For Science, Technology And Research Peptides and their uses
WO2014053879A1 (en) 2012-10-04 2014-04-10 Centre National De La Recherche Scientifique Cell penetrating peptides for intracellular delivery of molecules
DK3237436T3 (da) * 2014-12-24 2019-08-12 Aadigen Llc Peptider og nanopartikler til intracellulær indgivelse af molekyler
SG11201708815UA (en) * 2015-05-29 2017-12-28 Hexima Ltd A method of in vivo treatment
CN105749250A (zh) * 2016-03-14 2016-07-13 吉林大学 林蛙抗菌肽在治疗灰指甲的药物制备中的用途
CN116376795B (zh) * 2023-03-29 2023-11-07 中国水产科学研究院珠江水产研究所 一种表达hsp70的重组乳酸菌及其制备方法与应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5294605A (en) 1990-07-19 1994-03-15 The Scripps Research Institute Amphiphilic peptide compositions and analogues thereof
US5344822A (en) 1992-08-12 1994-09-06 The Rogosin Institute Methods useful in endotoxin prophylaxis and therapy
FR2697022B1 (fr) * 1992-10-19 1994-12-16 Pasteur Institut Antigènes de Plasmodium falciparum capables d'induire des anticorps protecteurs à large spectre - Application à la vaccination.
GB9705831D0 (en) 1997-03-20 1997-05-07 Univ Leicester Oxidised ldl
KR100314721B1 (ko) 1998-01-22 2001-11-23 김일웅 생물학적 활성이 있는 신규한 펩타이드
WO1999045950A2 (en) 1998-03-11 1999-09-16 Duke University Methods of suppressing microglial activation
US7205280B2 (en) * 1998-03-11 2007-04-17 Cognosci, Inc. Methods of suppressing microglial activation
US6664230B1 (en) 2000-08-24 2003-12-16 The Regents Of The University Of California Orally administered peptides to ameliorate atherosclerosis
GB0103424D0 (en) 2001-02-12 2001-03-28 Chiron Spa Gonococcus proteins
US20040014955A1 (en) 2001-12-17 2004-01-22 Carlos Zamudio Identification of essential genes of cryptococcus neoformans and methods of use
US20050058689A1 (en) * 2003-07-03 2005-03-17 Reactive Surfaces, Ltd. Antifungal paints and coatings
US20050208078A1 (en) * 2003-11-20 2005-09-22 Hoffman Stephen L Methods for the prevention of malaria
CA2541117A1 (en) 2003-10-01 2005-05-06 Children's Hospital & Research Center At Oakland Lipophilic drug delivery vehicle and methods of use thereof
GB0329254D0 (en) * 2003-12-17 2004-01-21 Univ Manchester Treatment of viral infections
ITFI20030324A1 (it) 2003-12-22 2005-06-23 Celbo S R L Gruppo guidafilo per distribuire ed avvolgere filati per formare bobine.
GB0329958D0 (en) * 2003-12-24 2004-01-28 Univ Manchester Treatment of viral infections
GB0404374D0 (en) * 2004-02-27 2004-03-31 Univ Manchester Treatment of bacterial infections
GB0513096D0 (en) 2005-06-28 2005-08-03 Strathclyde Treatment of microbial infections

Also Published As

Publication number Publication date
EP1896502B1 (en) 2013-07-31
US20120258907A1 (en) 2012-10-11
US20080207508A1 (en) 2008-08-28
ES2427171T3 (es) 2013-10-29
PL1896502T3 (pl) 2013-12-31
CA2610720A1 (en) 2007-01-04
RU2008102928A (ru) 2009-08-10
WO2007000584A1 (en) 2007-01-04
JP2008546831A (ja) 2008-12-25
KR20110099069A (ko) 2011-09-05
GB0513096D0 (en) 2005-08-03
DK1896502T3 (da) 2013-10-14
US8916516B2 (en) 2014-12-23
WO2007000584A8 (en) 2013-01-24
EP1896502A1 (en) 2008-03-12
CN101208355A (zh) 2008-06-25
US20150190462A1 (en) 2015-07-09
AU2006263600A1 (en) 2007-01-04
BRPI0612103A2 (pt) 2011-12-20
AU2006263600B2 (en) 2012-09-20
KR20080030060A (ko) 2008-04-03

Similar Documents

Publication Publication Date Title
HK1113162A1 (en) Treatment of fungal and/or protist infections
IL232501A (en) Peptide or polypeptide-resistant protein analogs and their uses
GB0404374D0 (en) Treatment of bacterial infections
MX2010002716A (es) Uso de slit, nefrina, efrina o semaforina para el tratamiento de enfermedades de cartilago.
ATE462006T1 (de) Isoform des vegfs
SG158141A1 (en) Pancreatic polypeptide family motifs, polypeptides and methods comprising the same
PT2078038E (pt) Agentes tensioativos reconstituídos apresentando propriedades melhoradas
HRP20080413T3 (en) Medicament for the treatment of fungal infections, particularly aspergillosis
SG10201803541TA (en) Biologically active c-terminal arginine-containing peptides
WO2002100895A3 (de) Antimikrobiell wirkendes peptid
SG170109A1 (en) Proteins, nucleic acids and medicaments
NZ589365A (en) Peptidyl diacylglycerides
WO2007016593A3 (en) Antifungal peptides and methods of use thereof
AU2003251728A8 (en) Placental growth factor as a target for the treatment of osteoporosis
CY1111630T1 (el) Παραγωγα κυτοκινων
WO2004041859A3 (fr) Fragments peptidiques du facteur harp inhibant l&#39;angiogenese
ATE518878T1 (de) Antimikrobielle peptide
ATE485831T1 (de) Behandlung von neurodegeneration
DE60130922D1 (de) Peptide mit inhibierender Aktivität zur Produktion von Stickstoffmonoxid
TW200700431A (en) Recombinant expression of defensins in filamentous fungi
WO2006126198A3 (en) Arts c-terminus fragments and mimetics thereof
WO2003025014A3 (fr) Utilisation de peptides comportant des modifications de type post-traductionnel dans le cadre du traitement de pathologies auto-immunes
WO2006074341A3 (en) Novel use
ATE467643T1 (de) Peptide mit proliferationshemmender wirkung
WO2007073845A3 (en) Polypeptide having esterase activity and recombinant esterase and use thereof

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20220626